Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.218
-0.012 (-0.97%)
At close: Nov 4, 2024, 4:00 PM
1.200
-0.018 (-1.49%)
After-hours: Nov 4, 2024, 4:40 PM EST

Dermata Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
4.473.974.024.41.571.85
Research & Development
5.654.075.653.461.612.62
Operating Expenses
10.128.049.677.863.174.47
Operating Income
-10.12-8.04-9.67-7.86-3.17-4.47
Interest Expense
----0.05-0.2-0.25
Interest & Investment Income
0.30.250.06---
EBT Excluding Unusual Items
-9.82-7.79-9.61-7.9-3.37-4.72
Other Unusual Items
----0.13-
Pretax Income
-9.82-7.79-9.61-7.9-3.24-4.72
Net Income
-9.82-7.79-9.61-7.9-3.24-4.72
Preferred Dividends & Other Adjustments
---2.56--
Net Income to Common
-9.82-7.79-9.61-10.46-3.24-4.72
Shares Outstanding (Basic)
0000--
Shares Outstanding (Diluted)
0000--
Shares Change (YoY)
373.37%323.42%156.86%---
EPS (Basic)
-23.74-39.98-208.73-583.77--
EPS (Diluted)
-23.74-39.98-208.73-583.77--
Free Cash Flow
-7.75-6.41-8.83-5.69-4.03-3.92
Free Cash Flow Per Share
-18.74-32.87-191.86-317.61--
EBITDA
----7.86-3.17-4.47
D&A For EBITDA
---000
EBIT
-10.12-8.04-9.67-7.86-3.17-4.47
Source: S&P Capital IQ. Standard template. Financial Sources.